Protocols
|
July 26, 2023

A Functional Medicine Interstitial Cystitis Protocol: Testing, Nutrition, and Supplements

Medically Reviewed by
Updated On
September 17, 2024

Interstitial cystitis is a chronic pain disorder with an estimated prevalence of 3-8 million women and 1-4 million men in the United States. However, these numbers may be underestimated given the difficulties associated with diagnosis that lead to underdiagnosis, especially in men. (31)

Given the complexity of interstitial cystitis, research suggests that a multimodal, integrative treatment plan, including diet therapy, stress management, and physiotherapy, can lead to treatment success rates of over 90%. This article will discuss a holistic approach to interstitial cystitis and provide a sample treatment plan that can be implemented in clinical practice.

[signup]

What Is Interstitial Cystitis?

Interstitial cystitis (IC) is also known as painful bladder syndrome (PBS) and bladder pain syndrome (BPS). It is a chronic pelvic pain condition characterized by recurring urinary urgency and frequency and pain or pressure in the bladder and pelvic region, lasting at least six weeks without infection or other apparent cause. IC affects millions of men and women but is most common in women in their 30s or older. (40

Interstitial Cystitis & Symptoms

The signs and symptoms of IC can vary among individuals, and some people may experience periodic remissions and flare-ups. Common signs and symptoms of IC mimic those of a urinary tract infection (UTI): 

  • Pelvic pain or discomfort ranging from mild to severe is described as an aching, pressure, or burning sensation in the pelvic region and the bladder. This sensation is worsened by filling the bladder and is often relieved by urinating.
  • Urinary frequency and urgency: urinating more often than usual and urgently, even when the bladder is not full. Patients often wake frequently during the night to urinate (nocturia). 
  • Painful urination (dysuria): urinating is accompanied by pain or a burning sensation
  • Pain during sexual intercourse (dyspareunia) 

Root Causes of Interstitial Cystitis

The exact cause of IC remains unknown, and it is believed to be a multifactorial condition with various contributing factors leading to inflammation. 

One possible cause is a disruption in the bladder's protective lining, known as the urothelium, which can make the bladder more susceptible to irritation and inflammation. When the urothelium is healthy, it acts as a barrier, preventing irritating substances in the urine from directly contacting the underlying bladder tissue. However, the urothelium may become compromised in individuals with IC, leading to increased permeability or "leakiness." A leaky urothelium allows toxins, bacteria, and inflammatory mediators to penetrate the bladder tissue, leading to chronic bladder inflammation and irritation. (31)

Dysregulation of the immune system has been implicated in IC. It is thought that an autoimmune response or chronic low-grade inflammation in the bladder may contribute to the development and progression of the condition. Immunoglobulin and immune mediators are detected at higher levels in the urine of affected individuals. A growing body of evidence suggests a correlation between IC and histamine intolerance, as histamine released during an immune response can contribute to bladder inflammation and trigger IC symptoms in susceptible individuals. (31)

Ongoing research is exploring the connection between the urinary microbiome and IC. Traditionally, urine was believed to be sterile, but recent studies have shown that the urinary tract contains a diverse microbial community. In individuals with IC, imbalances or dysbiosis in the urinary microbiome have been observed, potentially contributing to the development or worsening of IC symptoms. It is hypothesized that these microbiome alterations may trigger chronic inflammation and immune responses in the bladder; specific microorganisms within the urinary microbiome could directly irritate the bladder or disrupt its normal function. (6

Other factors contributing to IC include pelvic floor dysfunction, nerve abnormalities, and lifestyle factors such as diet and stress. Pelvic floor dysfunction can increase tension or weakness in the pelvic muscles, leading to bladder dysfunction and pain. Nerve abnormalities in the urinary system can disrupt the communication between the bladder and the brain, contributing to IC symptoms. Moreover, dietary triggers such as acidic foods, caffeine, artificial sweeteners, alcohol, and other food sensitivities may exacerbate IC symptoms in some individuals. Psychological stress can also worsen symptoms, as the stress response can affect the immune system and trigger inflammation. (2)

How to Diagnose Interstitial Cystitis

IC remains challenging to diagnose given the lack of a definitive diagnostic test to determine its presence; therefore, it remains a diagnosis of exclusion, meaning that other diagnoses must be excluded first before landing on IC as the cause of symptoms.

Step 1: History and Physical Examination

 A comprehensive patient history should confirm the presence of pelvic pain, pressure, or discomfort related to the bladder. Pain is often associated with the persistent urge to void or urinary frequency. Symptoms should be present for at least six weeks. (23

Doctors will also perform a comprehensive physical exam to help find other explainable causes for symptoms. This will include a pelvic and digital rectal exam to see if symptoms are related to spasms in the pelvic floor muscles, infection, or prostate problems. (17

Step 2: Laboratory Assessment to Rule Out Other Pathology

The differential diagnosis for chronic pelvic/bladder pain should include: 

  • Urinary tract infection
  • Bladder cancer
  • Overactive bladder syndrome
  • Chronic prostatitis
  • Endometriosis
  • Vaginitis
  • Bladder or lower ureteral stone
  • Urogenital prolapse
  • Pelvic floor muscle-related pain

The following labs can be ordered as part of an initial evaluation to narrow the differential: 

Step 3: Labs to Uncover the Root Causes of Interstitial Cystitis 

Although there isn't a definitive test to rule in the diagnosis, specialty labs can assist in uncovering the underlying imbalances contributing to urinary inflammation and symptoms. 

Microbiome Testing

While urinary microbiome testing is not readily available, research suggests that the gastrointestinal microbiota may influence the urinary tract. Reductions in certain types of bacteria have been measured in patients with IC. Additionally, gastrointestinal dysbiosis is a known trigger for immunological dysfunction, immune hyperreactivity, and systemic inflammation.

A stool test collected at home by the patient can assess the patient's complete gut microbiome and function. Examples include: 

SIBO Breath Test

In a 12-year cohort study, irritable bowel syndrome (IBS) increased the risk of developing IC. The study found that, on average, it took approximately five years from diagnosing IBS to developing IC. Additionally, these results suggest that shared common factors may contribute to the development of both conditions. 

Studies suggest that up to 80% of people with IBS have small intestinal bacterial overgrowth (SIBO), contributing to their digestive symptoms. The following SIBO breath tests measure gaseous byproducts derived by intestinal microbes to diagnose and differentiate between the various SIBO subtypes.

Histamine

Histamine is a chemical compound involved in immune responses, inflammation, and allergic reactions. Studies have observed increased expression of histamine receptors in bladder tissue samples retrieved from patients with IC and that antihistamines improve IC-related pelvic pain. 

Measuring histamine with one of the following labs can help assess histamine intolerance as a contributor to bladder inflammation and assist in monitoring treatment effectiveness.

Food Sensitivities

Research reveals that patients with IC have significantly more food sensitivities than those without. Some studies indicate that as many as 90% of patients with IC report food sensitivities. 

A comprehensive panel that measures immune-mediated reactions to common food allergens can help identify dietary-related IC triggers and refine therapeutic dietary modification recommendations:

Hormone Panel

IC symptoms in women often fluctuate with hormonal changes, with some experiencing their first symptoms during perimenopause or menopause. This connection is likely linked to estrogen levels. A decrease in estrogen can activate mast cells, so many women may begin to experience IC symptoms leading up to menopause. Furthermore, inflammation, mast cell activity, and estrogen affect the bladder lining and detrusor muscle, potentially causing thinning, dryness, and increased susceptibility to inflammatory changes. Restoring hormonal balance becomes crucial in reducing the susceptibility to IC. (2

One of the following hormone panels can help identify and correlate hormonal imbalances with IC symptoms throughout the various phases of the menstrual cycle. 

[signup]

Treatment Plan for Interstitial Cystitis

Once IC has been diagnosed and its root causes have been identified, an integrative treatment plan incorporating dietary modifications to reduce inflammatory triggers, stress management techniques, interventions to restore a healthy microbiome, and other targeted therapies to support bladder health and immune function can be implemented. 

Step 1: Reduce Inflammation

Here's Why This Is Important:

Inflammation is recognized as a key contributor to the symptoms and progression of the disease.

How Do You Do This?

Therapeutic dietary modifications play an important role in managing the symptoms of IC. While there is no one-size-fits-all diet for IC, certain nutritional changes have shown promise in reducing bladder irritation and alleviating symptoms. (21, 34)

  • Avoidance of Trigger Foods: Per patient survey, common IC trigger foods include coffee, alcohol, citrus fruits, tomatoes, carbonated drinks, and spicy foods. Food sensitivity testing can also help customize elimination diets. Avoiding trigger foods usually results in symptom improvement within 1-2 weeks. (2
  • Another dietary approach is the IC diet, which focuses on consuming bladder-friendly foods that are less likely to irritate the bladder. This typically includes low-acid foods like pears, apples, green vegetables, lean proteins, whole grains, and non-citrus juices. 

The following natural supplements possess anti-inflammatory properties that convey benefits to patients with IC: 

  • Quercetin is a flavonoid with antioxidant and anti-inflammatory properties. It modulates the immune response and inhibits the release of histamine and other inflammatory mediators from mast cells. This small study showed that patients who took 500 mg of quercetin twice daily for just four weeks experienced improvement in IC urinary symptoms and pain scores.
  • Kava (Piper methysticum) has been used historically as a urinary antispasmodic and anti-inflammatory agent. It can also be used as a natural anxiolytic agent, helpful in IC cases reported to be aggravated by stress, or to support the general emotional well-being of patients. A typical dose recommendation for kava is 70 mg of kavalactones three times daily.

Step 2: Improve Bladder Structure & Function

Why Is This Important?

The loss of the urothelial barrier is considered another key factor in IC pathogenesis. Treatments that aim to improve bladder structure and function help repair the damaged urothelium, enhance the bladder's protective barrier against inflammation, and restore its normal capacity.

How Do You Do This?

Bladder training techniques, which involve gradually increasing the time between urinations, may be recommended to improve bladder capacity and reduce urgency. (31

Glycosaminoglycans (GAGs) are naturally occurring substances contributing to the protective urothelium. GAG supplementation aims to restore and support the integrity of the urothelium to reduce bladder irritation. Clinical studies have shown that GAG supplementation in doses as low as 100 mg three times daily can improve urinary symptoms, decrease pain, and enhance bladder capacity in some individuals with IC.

Arginine is an amino acid that plays a role in various physiological processes, including wound healing and immune function. Some individuals with IC may consider arginine supplementation due to its potential vasodilatory effects and its involvement in nitric oxide synthesis, which can impact bladder function. Although evidence is limited, several studies have reported positive benefits of L-arginine supplementation in treating IC. For example, one study reported increased urinary nitric oxide-related enzymes and metabolites, combined with reduced IC symptoms, with long-term L-arginine supplementation (dosed 1,500 mg daily for six months).

More invasive procedures may be considered for individuals with severe IC symptoms that are unresponsive to other treatments. These can include bladder distention, where the bladder is filled with fluid to stretch the bladder wall and reduce pain signals, or neuromodulation techniques, such as sacral nerve stimulation or botulinum toxin injections, which aim to regulate nerve signaling and improve bladder function. (2, 31)

Step 3: Alleviate Symptoms

Why Is This Important?

The debilitating symptoms of IC possess the capacity to negatively impact work productivity, mood, sleep, sexual function, and mobility. Many of the strategies discussed above take months to produce clinically impactful changes. Patients with severe symptoms may require faster-acting palliative interventions to improve quality of life metrics. In some cases, doctors may consider including the following interventions in their initial treatment plan to provide symptomatic relief to patients.

How Do You Do This?

Medications can play a significant role in managing IC symptoms. Oral medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), antihistamines, and tricyclic antidepressants (TCAs) can help alleviate pain, reduce inflammation, and improve sleep quality. Additionally, bladder-instilled medications, such as pentosan polysulfate sodium (PPS) or lidocaine, may be administered directly into the bladder to provide localized relief. (19, 31)

Sacral or pudendal nerve stimulation may reduce urinary frequency and urgency associated with IC (19). A thin wire is placed near the nerve during this procedure to send electrical impulses to the bladder (26).  

Risks of Untreated Interstitial Cystitis

IC can lead to various complications that can significantly impact a person's quality of life. These complications may include chronic pain, sleep disturbances due to nocturia, emotional distress such as anxiety and depression, and decreased sexual intimacy and satisfaction. Additionally, the chronic nature of IC and the constant need to manage symptoms can lead to limitations in daily activities, work productivity, and social interactions. (26)

Interstitial Cystitis Case Study

You can read about a real case study here: 

Case Study: Sarah's 5 Month Integrative Medicine Journey That Healed Her Interstitial Cystitis

[signup]

Key Takeaways:

  • Interstitial cystitis can cause debilitating bladder and pelvic pain for affected individuals. 
  • The complexity of IC, along with the lack of definitive diagnostic testing available, makes it underdiagnosed and challenging to manage. 
  • Medical guidelines for treatment call for a multifaceted approach to effectively manage symptoms and improve affected patients' quality of life. Achieving a pain-free life is possible using an integrative treatment approach that targets the underlying pathophysiology contributing to bladder irritation and inflammation.

Interstitial cystitis is a chronic pain disorder with an estimated prevalence of 3-8 million women and 1-4 million men in the United States. However, these numbers may be underestimated given the difficulties associated with diagnosis that lead to underdiagnosis, especially in men. (31)

Given the complexity of interstitial cystitis, research suggests that a multimodal, integrative approach, including diet therapy, stress management, and physiotherapy, may help manage symptoms effectively. This article will discuss a holistic approach to interstitial cystitis and provide a sample plan that can be considered in clinical practice.

[signup]

What Is Interstitial Cystitis?

Interstitial cystitis (IC) is also known as painful bladder syndrome (PBS) and bladder pain syndrome (BPS). It is a chronic pelvic pain condition characterized by recurring urinary urgency and frequency and pain or pressure in the bladder and pelvic region, lasting at least six weeks without infection or other apparent cause. IC affects millions of men and women but is most common in women in their 30s or older. (40

Interstitial Cystitis & Symptoms

The signs and symptoms of IC can vary among individuals, and some people may experience periodic remissions and flare-ups. Common signs and symptoms of IC mimic those of a urinary tract infection (UTI): 

  • Pelvic pain or discomfort ranging from mild to severe is described as an aching, pressure, or burning sensation in the pelvic region and the bladder. This sensation is worsened by filling the bladder and is often relieved by urinating.
  • Urinary frequency and urgency: urinating more often than usual and urgently, even when the bladder is not full. Patients often wake frequently during the night to urinate (nocturia). 
  • Painful urination (dysuria): urinating is accompanied by pain or a burning sensation
  • Pain during sexual intercourse (dyspareunia) 

Root Causes of Interstitial Cystitis

The exact cause of IC remains unknown, and it is believed to be a multifactorial condition with various contributing factors leading to inflammation. 

One possible cause is a disruption in the bladder's protective lining, known as the urothelium, which can make the bladder more susceptible to irritation and inflammation. When the urothelium is healthy, it acts as a barrier, preventing irritating substances in the urine from directly contacting the underlying bladder tissue. However, the urothelium may become compromised in individuals with IC, leading to increased permeability or "leakiness." A leaky urothelium allows toxins, bacteria, and inflammatory mediators to penetrate the bladder tissue, potentially leading to chronic bladder inflammation and irritation. (31)

Dysregulation of the immune system has been implicated in IC. It is thought that an autoimmune response or chronic low-grade inflammation in the bladder may contribute to the development and progression of the condition. Immunoglobulin and immune mediators are detected at higher levels in the urine of affected individuals. A growing body of evidence suggests a correlation between IC and histamine intolerance, as histamine released during an immune response can contribute to bladder inflammation and trigger IC symptoms in susceptible individuals. (31)

Ongoing research is exploring the connection between the urinary microbiome and IC. Traditionally, urine was believed to be sterile, but recent studies have shown that the urinary tract contains a diverse microbial community. In individuals with IC, imbalances or dysbiosis in the urinary microbiome have been observed, potentially contributing to the development or worsening of IC symptoms. It is hypothesized that these microbiome alterations may trigger chronic inflammation and immune responses in the bladder; specific microorganisms within the urinary microbiome could directly irritate the bladder or disrupt its normal function. (6

Other factors contributing to IC include pelvic floor dysfunction, nerve abnormalities, and lifestyle factors such as diet and stress. Pelvic floor dysfunction can increase tension or weakness in the pelvic muscles, leading to bladder dysfunction and pain. Nerve abnormalities in the urinary system can disrupt the communication between the bladder and the brain, contributing to IC symptoms. Moreover, dietary triggers such as acidic foods, caffeine, artificial sweeteners, alcohol, and other food sensitivities may exacerbate IC symptoms in some individuals. Psychological stress can also worsen symptoms, as the stress response can affect the immune system and trigger inflammation. (2)

How to Diagnose Interstitial Cystitis

IC remains challenging to diagnose given the lack of a definitive diagnostic test to determine its presence; therefore, it remains a diagnosis of exclusion, meaning that other diagnoses must be excluded first before considering IC as the cause of symptoms.

Step 1: History and Physical Examination

 A comprehensive patient history should confirm the presence of pelvic pain, pressure, or discomfort related to the bladder. Pain is often associated with the persistent urge to void or urinary frequency. Symptoms should be present for at least six weeks. (23

Doctors will also perform a comprehensive physical exam to help find other explainable causes for symptoms. This will include a pelvic and digital rectal exam to see if symptoms are related to spasms in the pelvic floor muscles, infection, or prostate problems. (17

Step 2: Laboratory Assessment to Rule Out Other Pathology

The differential diagnosis for chronic pelvic/bladder pain should include: 

  • Urinary tract infection
  • Bladder cancer
  • Overactive bladder syndrome
  • Chronic prostatitis
  • Endometriosis
  • Vaginitis
  • Bladder or lower ureteral stone
  • Urogenital prolapse
  • Pelvic floor muscle-related pain

The following labs can be ordered as part of an initial evaluation to narrow the differential: 

Step 3: Labs to Uncover the Root Causes of Interstitial Cystitis 

Although there isn't a definitive test to rule in the diagnosis, specialty labs can assist in uncovering the underlying imbalances contributing to urinary inflammation and symptoms. 

Microbiome Testing

While urinary microbiome testing is not readily available, research suggests that the gastrointestinal microbiota may influence the urinary tract. Reductions in certain types of bacteria have been measured in patients with IC. Additionally, gastrointestinal dysbiosis is a known trigger for immunological dysfunction, immune hyperreactivity, and systemic inflammation.

A stool test collected at home by the patient can assess the patient's complete gut microbiome and function. Examples include: 

SIBO Breath Test

In a 12-year cohort study, irritable bowel syndrome (IBS) increased the risk of developing IC. The study found that, on average, it took approximately five years from diagnosing IBS to developing IC. Additionally, these results suggest that shared common factors may contribute to the development of both conditions. 

Studies suggest that up to 80% of people with IBS have small intestinal bacterial overgrowth (SIBO), contributing to their digestive symptoms. The following SIBO breath tests measure gaseous byproducts derived by intestinal microbes to diagnose and differentiate between the various SIBO subtypes.

Histamine

Histamine is a chemical compound involved in immune responses, inflammation, and allergic reactions. Studies have observed increased expression of histamine receptors in bladder tissue samples retrieved from patients with IC and that antihistamines may help manage IC-related pelvic discomfort. 

Measuring histamine with one of the following labs can help assess histamine intolerance as a contributor to bladder inflammation and assist in monitoring treatment effectiveness.

Food Sensitivities

Research reveals that patients with IC have significantly more food sensitivities than those without. Some studies indicate that as many as 90% of patients with IC report food sensitivities. 

A comprehensive panel that measures immune-mediated reactions to common food allergens can help identify dietary-related IC triggers and refine therapeutic dietary modification recommendations:

Hormone Panel

IC symptoms in women often fluctuate with hormonal changes, with some experiencing their first symptoms during perimenopause or menopause. This connection is likely linked to estrogen levels. A decrease in estrogen can activate mast cells, so many women may begin to experience IC symptoms leading up to menopause. Furthermore, inflammation, mast cell activity, and estrogen affect the bladder lining and detrusor muscle, potentially causing thinning, dryness, and increased susceptibility to inflammatory changes. Supporting hormonal balance becomes crucial in reducing the susceptibility to IC. (2

One of the following hormone panels can help identify and correlate hormonal imbalances with IC symptoms throughout the various phases of the menstrual cycle. 

[signup]

Approaches to Managing Interstitial Cystitis

Once IC has been diagnosed and its root causes have been identified, an integrative approach incorporating dietary modifications to reduce inflammatory triggers, stress management techniques, interventions to support a healthy microbiome, and other targeted strategies to support bladder health and immune function can be considered. 

Step 1: Support Inflammation Management

Here's Why This Is Important:

Inflammation is recognized as a key contributor to the symptoms and progression of the condition.

How Do You Do This?

Therapeutic dietary modifications play an important role in managing the symptoms of IC. While there is no one-size-fits-all diet for IC, certain nutritional changes have shown promise in reducing bladder irritation and alleviating symptoms. (21, 34)

  • Avoidance of Trigger Foods: Per patient survey, common IC trigger foods include coffee, alcohol, citrus fruits, tomatoes, carbonated drinks, and spicy foods. Food sensitivity testing can also help customize elimination diets. Avoiding trigger foods usually results in symptom improvement within 1-2 weeks. (2
  • Another dietary approach is the IC diet, which focuses on consuming bladder-friendly foods that are less likely to irritate the bladder. This typically includes low-acid foods like pears, apples, green vegetables, lean proteins, whole grains, and non-citrus juices. 

The following natural supplements possess properties that may support individuals with IC: 

  • Quercetin is a flavonoid with antioxidant and anti-inflammatory properties. It modulates the immune response and inhibits the release of histamine and other inflammatory mediators from mast cells. This small study showed that patients who took 500 mg of quercetin twice daily for just four weeks experienced improvement in IC urinary symptoms and pain scores.
  • Kava (Piper methysticum) has been used historically as a urinary antispasmodic and anti-inflammatory agent. It can also be used as a natural anxiolytic agent, helpful in IC cases reported to be aggravated by stress, or to support the general emotional well-being of patients. A typical dose recommendation for kava is 70 mg of kavalactones three times daily.

Step 2: Support Bladder Structure & Function

Why Is This Important?

The loss of the urothelial barrier is considered another key factor in IC pathogenesis. Strategies that aim to support bladder structure and function may help maintain the integrity of the urothelium, enhance the bladder's protective barrier against inflammation, and support its normal capacity.

How Do You Do This?

Bladder training techniques, which involve gradually increasing the time between urinations, may be recommended to improve bladder capacity and reduce urgency. (31

Glycosaminoglycans (GAGs) are naturally occurring substances contributing to the protective urothelium. GAG supplementation aims to support the integrity of the urothelium to reduce bladder irritation. Clinical studies have shown that GAG supplementation in doses as low as 100 mg three times daily can improve urinary symptoms, decrease discomfort, and enhance bladder capacity in some individuals with IC.

Arginine is an amino acid that plays a role in various physiological processes, including wound healing and immune function. Some individuals with IC may consider arginine supplementation due to its potential vasodilatory effects and its involvement in nitric oxide synthesis, which can impact bladder function. Although evidence is limited, several studies have reported positive benefits of L-arginine supplementation in managing IC. For example, one study reported increased urinary nitric oxide-related enzymes and metabolites, combined with reduced IC symptoms, with long-term L-arginine supplementation (dosed 1,500 mg daily for six months).

More invasive procedures may be considered for individuals with severe IC symptoms that are unresponsive to other strategies. These can include bladder distention, where the bladder is filled with fluid to stretch the bladder wall and reduce pain signals, or neuromodulation techniques, such as sacral nerve stimulation or botulinum toxin injections, which aim to regulate nerve signaling and support bladder function. (2, 31)

Step 3: Alleviate Symptoms

Why Is This Important?

The debilitating symptoms of IC possess the capacity to negatively impact work productivity, mood, sleep, sexual function, and mobility. Many of the strategies discussed above take months to produce noticeable changes. Patients with severe symptoms may require faster-acting palliative interventions to improve quality of life metrics. In some cases, doctors may consider including the following interventions in their initial plan to provide symptomatic relief to patients.

How Do You Do This?

Medications can play a significant role in managing IC symptoms. Oral medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), antihistamines, and tricyclic antidepressants (TCAs) can help alleviate discomfort, reduce inflammation, and improve sleep quality. Additionally, bladder-instilled medications, such as pentosan polysulfate sodium (PPS) or lidocaine, may be administered directly into the bladder to provide localized relief. (19, 31)

Sacral or pudendal nerve stimulation may reduce urinary frequency and urgency associated with IC (19). A thin wire is placed near the nerve during this procedure to send electrical impulses to the bladder (26).  

Risks of Untreated Interstitial Cystitis

IC can lead to various complications that can significantly impact a person's quality of life. These complications may include chronic pain, sleep disturbances due to nocturia, emotional distress such as anxiety and depression, and decreased sexual intimacy and satisfaction. Additionally, the chronic nature of IC and the constant need to manage symptoms can lead to limitations in daily activities, work productivity, and social interactions. (26)

Interstitial Cystitis Case Study

You can read about a real case study here: 

Case Study: Sarah's 5 Month Integrative Medicine Journey That Supported Her Interstitial Cystitis Management

[signup]

Key Takeaways:

  • Interstitial cystitis can cause debilitating bladder and pelvic pain for affected individuals. 
  • The complexity of IC, along with the lack of definitive diagnostic testing available, makes it underdiagnosed and challenging to manage. 
  • Medical guidelines for management call for a multifaceted approach to effectively manage symptoms and improve affected patients' quality of life. Achieving a pain-free life is possible using an integrative approach that targets the underlying factors contributing to bladder irritation and inflammation.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.

Learn more

No items found.

Lab Tests in This Article

  1. Arginine. Rupa Health. Retrieved June 11, 2024, from https://www.rupahealth.com/biomarkers/arginine
  2. Arora, S. (2013, October 18). Interstitial cystitis. Women's Health Network. https://www.womenshealthnetwork.com/hormonal-imbalance/interstitial-cystitis/
  3. Bertagna, B. (2023, November 28). Kava For Anxiety: A Functional Medicine Perspective on Dosage, Benefits, and Considerations. Rupa Health. https://www.rupahealth.com/post/kava-for-anxiety-a-functional-medicine-perspective-on-dosage-benefits-and-considerations
  4. Bian, T., Corral, P., Wang, Y., et al. (2020). Kava as a Clinical Nutrient: Promises and Challenges. Nutrients, 12(10). https://doi.org/10.3390/nu12103044
  5. Braundmeier-Fleming, A., Russell, N. T., Yang, W., et al. (2016). Stool-based biomarkers of interstitial cystitis/bladder pain syndrome. Scientific Reports, 6(1), 26083. https://doi.org/10.1038/srep26083
  6. Bschleipfer, T., & Karl, I. (2022). Bladder Microbiome in the Context of Urological Disorders—Is There a Biomarker Potential for Interstitial Cystitis? Diagnostics, 12(2), 281. https://doi.org/10.3390/diagnostics12020281
  7. Cervigni, M. (2015). Interstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapy. Translational Andrology and Urology, 4(6), 638–642. https://doi.org/10.3978/j.issn.2223-4683.2015.11.04
  8. Chang, K.-M., Lee, M.-H., Lin, H.-H., et al. (2021). Does irritable bowel syndrome increase the risk of interstitial cystitis/bladder pain syndrome? A cohort study of long term follow-up. International Urogynecology Journal, 32(5). https://doi.org/10.1007/s00192-021-04711-3
  9. Choi, H. W., Lee, K. W., & Kim, Y. H. (2023). Microbiome in urological diseases: Axis crosstalk and bladder disorders. Investigative and Clinical Urology, 64(2), 126. https://doi.org/10.4111/icu.20220357
  10. Christie, J. (2022, April 7). 5 Common Root Causes Of Endometriosis And How To Treat Them. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-endometriosis
  11. Christie, J. (2022, July 21). Do You Experience Bladder Pain? It May Be Due To This Poorly Understood Condition. Rupa Health. https://www.rupahealth.com/post/do-you-experience-bladder-pain-it-may-be-due-to-this-poorly-understood-condition
  12. Clemens, J. Q. (2023). Patient education: Diagnosis of interstitial cystitis/bladder pain syndrome (Beyond the Basics). UpToDate. https://www.uptodate.com/contents/diagnosis-of-interstitial-cystitis-bladder-pain-syndrome-beyond-the-basics/print
  13. Cloyd, J. (2023, April 3). 5 Health Conditions That Are Associated with Small Intestinal Bacterial Overgrowth (SIBO). Rupa Health. https://www.rupahealth.com/post/5-health-conditions-that-are-associated-with-small-intestinal-bacterial-overgrowth-sibo
  14. Cloyd, J. (2023, June 14). A Complementary and Integrative Medicine Approach to Reoccurring UTIs: Specialty Testing, Supplements, and Nutrition Options. Rupa Health. https://www.rupahealth.com/post/a-complementary-and-integrative-med-approach-to-reoccurring-utis-testing-supplements-and-nutrition-options
  15. Cloyd, J. (2023, November 8). Quercetin 101: Getting to Know This Powerful Substance and How You Can Use it For Your Health. Rupa Health. https://www.rupahealth.com/post/quercetin-101-getting-to-know-this-powerful-substance-and-how-you-can-use-it-for-your-health
  16. Colemeadow, J., Sahai, A., & Malde, S. (2020). Clinical Management of Bladder Pain Syndrome/Interstitial Cystitis: A Review on Current Recommendations and Emerging Treatment Options. Research and Reports in Urology, 12, 331–343. https://doi.org/10.2147/rru.s238746
  17. Diagnosis of Interstitial Cystitis. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/urologic-diseases/interstitial-cystitis-painful-bladder-syndrome/diagnosis
  18. Ewumi, O. (2023, January 30). What to know about interstitial cystitis and diet. Medical News Today. https://www.medicalnewstoday.com/articles/interstitial-cystitis-diet
  19. French, L. M., & Bhambore, N. (2011). Interstitial Cystitis/Painful Bladder Syndrome. American Family Physician, 83(10), 1175–1181. https://www.aafp.org/pubs/afp/issues/2011/0515/p1175.html#treatment-options
  20. Friedlander, J. I., Shorter, B., & Moldwin, R. M. (2012). Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU International, 109(11), 1584–1591. https://doi.org/10.1111/j.1464-410x.2011.10860.x
  21. Gordon, B., Shorter, B., Sarcona, A., et al. (2015). Nutritional Considerations for Patients with Interstitial Cystitis/Bladder Pain Syndrome. Journal of the Academy of Nutrition and Dietetics, 115(9), 1372–1375. https://doi.org/10.1016/j.jand.2015.03.021
  22. Grover, S., Srivastava, A., Lee, R., et al. (2011). Role of inflammation in bladder function and interstitial cystitis. Therapeutic Advances in Urology, 3(1), 19–33. https://doi.org/10.1177/1756287211398255
  23. Hanno, P. M., Erickson, D., Moldwin, R., et al. (2015). Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. The Journal of Urology, 193(5), 1545–1553. https://doi.org/10.1016/j.juro.2015.01.086
  24. Histamine. Rupa Health. Retrieved June 11, 2024, from https://www.rupahealth.com/biomarkers/histamine
  25. Ho, M. H., Bhatia, N. N., & Khorram, O. (2004). Physiologic role of nitric oxide and nitric oxide synthase in female lower urinary tract. Current Opinion in Obstetrics & Gynecology, 16(5), 423–429. https://doi.org/10.1097/00001703-200410000-00012
  26. Interstitial cystitis. (2019). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/interstitial-cystitis/symptoms-causes/syc-20354357
  27. Jarman, A., Janes, J. L., Shorter, B., et al. (2023). Food Sensitivities in a Diverse Nationwide Cohort of Veterans With Interstitial Cystitis/Bladder Pain Syndrome. The Journal of Urology, 209(1), 216–224. https://doi.org/10.1097/JU.0000000000002938
  28. Jones, B. M., & Tykocki, N. R. (2020). New direct evidence that histamine augments bladder sensory outflow during filling is nothing to sneeze at. American Journal of Physiology-Renal Physiology, 318(2), F455–F456. https://doi.org/10.1152/ajprenal.00581.2019
  29. Katske, F., Shoskes, D. A., Sender, M., et al. (2001). Treatment of interstitial cystitis with a quercetin supplement. Techniques in Urology, 7(1), 44–46. https://pubmed.ncbi.nlm.nih.gov/11272677/
  30. Klingler, C. H. (2016). Glycosaminoglycans: How Much do We Know about their Role in the Bladder? Urologia Journal, 83(1_suppl), 11–14. https://doi.org/10.5301/uro.5000184
  31. Lim, Y., Leslie, S. W., & O'Rourke, S. (2021, April 20). Interstitial Cystitis/Bladder Pain Syndrome. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK570588/
  32. Magerman, R. (2024, March 19). Natural Ways to Increase Nitric Oxide Levels. Rupa Health. https://www.rupahealth.com/post/natural-ways-to-increase-nitric-oxide-levels
  33. Perez-Carrasco, V., Soriano-Lerma, A., Soriano, M., et al. (2021). Urinary Microbiome: Yin and Yang of the Urinary Tract. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.617002
  34. Rahnama'i, M. S., Javan, A., Vyas, N., et al. (2020). Bladder Pain Syndrome and Interstitial Cystitis Beyond Horizon: Reports from the Global Interstitial Cystitis/Bladder Pain Society (GIBS) Meeting 2019 Mumbai – India. Anesthesiology and Pain Medicine, 10(3). https://doi.org/10.5812/aapm.101848
  35. Rudick, C. N., Bryce, P. J., Guichelaar, L. A., et al. (2008). Mast Cell-Derived Histamine Mediates Cystitis Pain. PLos One, 3(5), e2096–e2096. https://doi.org/10.1371/journal.pone.0002096
  36. Shan, H., Zhang, E., Zhang, P., et al. (2019). Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/interstitial cystitis – significance in the responsiveness to antihistamine treatment and disease symptoms. BMC Urol, 19(1). https://doi.org/10.1186/s12894-019-0548-3
  37. van Ginkel, C., Hurst, R. E., & Janssen, D. (2024). The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models. Current Opinion in Urology, 34(2), 77–83. https://doi.org/10.1097/MOU.0000000000001147
  38. Vasudevan, V., & Moldwin, R. (2017). Addressing quality of life in the patient with interstitial cystitis/bladder pain syndrome. Asian Journal of Urology, 4(1), 50–54. https://doi.org/10.1016/j.ajur.2016.08.014
  39. Vazquez, K. (2022, August 22). How Gut Dysbiosis Negatively Affects Hormone Regulation, Immune System Activation, and Neurotransmitter Production. Rupa Health. https://www.rupahealth.com/post/how-gut-dysbiosis-negatively-affects-hormone-regulation-immune-system-activation-and-neurotransmitter-production
  40. What is Interstitial Cystitis(IC)/Bladder Pain Syndrome? (2023). Urology Care Foundation. https://www.urologyhealth.org/urology-a-z/i/interstitial-cystitis
  41. Wheeler, M. A., Smith, S. M., Saito, N., et al. (1997). EFFECT OF LONG-TERM ORAL L-ARGININE ON THE NITRIC OXIDE SYNTHASE PATHWAY IN THE URINE FROM PATIENTS WITH INTERSTITIAL CYSTITIS. J Urol, 158(6), 2045–2050. https://doi.org/10.1016/s0022-5347(01)68150-3
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Protocols
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.